Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg

Showing results (211-220 of 333) with videos related to

Pageof 34
Sort By:
JHEP Reports : Innovation in Hepatology|April 18, 2022
Metabolic signatures across the full spectrum of non-alcoholic fatty liver diseaseAidan J McGlinchey, Olivier Govaere, Dawei Geng, et al.
International Journal of Oncology|February 27, 2013
Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinomaAnja Lautem, Michael Heise, Andreas Gräsel, et al.
Ophthalmology|February 19, 2025
Incidence of Retinal Vein Occlusion and Its Association with Mortality: Results from the Gutenberg Health StudyAnna Maria Voigt, Hisham Elbaz, Elsa Wilma Böhm, et al.
Iscience|September 6, 2022
Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver diseasePartho Sen, Olivier Govaere, Tim Sinioja, et al.
Scientific Reports|March 7, 2024
Noise annoyance and cardiovascular disease risk: results from a 10-year follow-up studyOmar Hahad, Donya Gilan, Matthias Michal, et al.
Annals of Hepatology|April 23, 2022
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in GermanyWolfgang Maximilian Kremer, Simon Johannes Gairing, Leonard Kaps, et al.
Investigative Ophthalmology & Visual Science|January 4, 2024
Change of Intraocular Pressure Over 5 Years and its Relationship to Cardiovascular Parameters: Results From the Gutenberg Health StudyAlica Hartmann, Ida Scholz, Esther M Hoffmann, et al.
Alimentary Pharmacology & Therapeutics|October 3, 2023
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitisStephen A Harrison, Vlad Ratziu, Quentin M Anstee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2021
Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim AnalysisZobair M Younossi, Maria Stepanova, Fatema Nader, et al.
Plos One|April 1, 2021
Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive careL Kaps, C J Ahlbrand, R Gadban, et al.
Pageof 34

Showing results (211-220 of 333) with videos related to

Sort By:
Pageof 34
JHEP Reports : Innovation in Hepatology|April 18, 2022
Metabolic signatures across the full spectrum of non-alcoholic fatty liver diseaseAidan J McGlinchey, Olivier Govaere, Dawei Geng, et al.
International Journal of Oncology|February 27, 2013
Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinomaAnja Lautem, Michael Heise, Andreas Gräsel, et al.
Ophthalmology|February 19, 2025
Incidence of Retinal Vein Occlusion and Its Association with Mortality: Results from the Gutenberg Health StudyAnna Maria Voigt, Hisham Elbaz, Elsa Wilma Böhm, et al.
Iscience|September 6, 2022
Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver diseasePartho Sen, Olivier Govaere, Tim Sinioja, et al.
Scientific Reports|March 7, 2024
Noise annoyance and cardiovascular disease risk: results from a 10-year follow-up studyOmar Hahad, Donya Gilan, Matthias Michal, et al.
Annals of Hepatology|April 23, 2022
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in GermanyWolfgang Maximilian Kremer, Simon Johannes Gairing, Leonard Kaps, et al.
Investigative Ophthalmology & Visual Science|January 4, 2024
Change of Intraocular Pressure Over 5 Years and its Relationship to Cardiovascular Parameters: Results From the Gutenberg Health StudyAlica Hartmann, Ida Scholz, Esther M Hoffmann, et al.
Alimentary Pharmacology & Therapeutics|October 3, 2023
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitisStephen A Harrison, Vlad Ratziu, Quentin M Anstee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2021
Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim AnalysisZobair M Younossi, Maria Stepanova, Fatema Nader, et al.
Plos One|April 1, 2021
Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive careL Kaps, C J Ahlbrand, R Gadban, et al.
Pageof 34